Substance Use Disorders in Perinatal Patients: Part Two
Overview
Perinatal substance use disorders (SUDs) affect up to 10% of pregnant and newly postpartum people. An enormous amount of stigma and shame prevents many of these patients from seeking much-needed care. This is the second of a two-part series exploring the epidemiology, presentations, and treatments for specific substances commonly used in Los Angeles County, including alcohol, cannabis, methamphetamine, and opioids. In particular, we will review the most current evidence-based practices for medication-assisted treatment, where they are available, and what we know about their safety data in pregnancy and breastfeeding.
Learning objectives
- Explain the evidence base for medication-assisted treatment of substance use disorders in perinatal patients
- Assess the risks of ongoing substance use for the baby-birthing person dyad, as well as the risks of medication-assisted treatment (MAT) in perinatal patients, based on the available data
- List 2 resources available to support prescribers serving birthing people with substance use disorders, including calling PROMISE for assistance
Professional credit
- This activity offers the following types of credit: APA, ABP-MOC, ABIM-MOC, ANCC, ASWB, ACCME, AAPA
- 1.0 CEs are available.